Class-Action Lawsuit Filed Against Humana Inc. for Alleged Misleading Statements on Financial Performance

cp6225 financial news generic cover c03c5832 d66d 4631 93f1 1532279cc789 - Class-Action Lawsuit Filed Against Humana Inc. for Alleged Misleading Statements on Financial Performance cp6225 financial news generic cover c03c5832 d66d 4631 93f1 1532279cc789 - Class-Action Lawsuit Filed Against Humana Inc. for Alleged Misleading Statements on Financial Performance
A class-action lawsuit has been filed on behalf of investors of Humana Inc. (“Humana” or the “Company”) by The Portnoy Law Firm. Investors who faced losses on their investments are urged to contact the law firm to learn more about potentially recovering their losses. Those who purchased Humana shares between July 27, 2022, and January 24, 2024, are particularly encouraged to reach out to attorney Lesley F. Portnoy. The filing alleges that defendants within Humana made false statements regarding the Company’s adjusted earnings per share, misleading investors about the impact of increased medical costs on the Company’s financials.

The lawsuit claims that Humana downplayed the effects of rising healthcare procedure costs due to pent-up demand, leading to higher utilization rates and expenses. Investors affected by these alleged misleading statements are advised to connect with The Portnoy Law Firm for a complimentary case evaluation. The Firm specializes in representing investors affected by corporate misconduct and has recovered over $5.5 billion for investors. Lesley F. Portnoy, Esq., a member of the California and New York Bar, can be contacted via phone or email to discuss investors’ legal rights and potential claims to recover their investment losses.

Investors looking to understand more about the lawsuit, their legal rights, and how to pursue claims to recover their losses can visit The Portnoy Law Firm’s website or contact attorney Lesley F. Portnoy directly. The Company is committed to providing support to investors who may have been impacted by the alleged dishonesty or lack of disclosures related to Humana’s financial performance. For more details and to submit transaction information, interested parties are directed to the Firm’s website.

Article Source